Skip to Content

Tong Ren Tang Technologies Co Ltd Class H TGRNF

Rating as of

Morningstar’s Analysis

Currency in USD
Is it the right time to buy or sell?
Find out with Morningstar Premium
Is it the right time to buy or sell?
Find out with Morningstar Premium

1-Star Price


5-Star Price


Economic Moat


About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Company Profile

Business Description

Tong Ren Tang Technologies is a major drug manufacturing company that focuses on traditional Chinese medicines. The company's growth strategy is to establish strategic marketing alliances with major distributors and strengthen cooperation with the medical product distributors of the Tong Ren Tang brand. The company derives revenue primarily from the manufacturing and sale of Chinese medicine in mainland China, followed by its activity in the manufacturing and wholesale of Chinese medicine and healthcare products.

No. 16 Tongji Beilu, Beijing Economic and Technological Development Zone
Beijing, China, People's Republic of
Sector Healthcare
Industry Drug Manufacturers - General
Most Recent Earnings
Fiscal Year End Dec 31, 2021
Stock Type
Employees 3,877